# Systems Biological Analysis of Immune Responses to RSV Vaccine

> **NCT07185399** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Emory University** · enrollment: 14 (actual)

## Conditions studied

- Respiratory Syncytial Virus (RSV)

## Interventions

- **BIOLOGICAL:** Moderna RSV vaccine

## Key facts

- **NCT ID:** NCT07185399
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-10-13
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2026-01-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07185399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07185399, "Systems Biological Analysis of Immune Responses to RSV Vaccine". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT07185399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*